Budget 2021: Pharma sector expects a booster shot, tax sops from FM Nirmala Sitharaman
With a cohesive effort from both public and private players, the Indian bio-pharma industry has the potential to unlock tremendous growth over the next few years
Vamsi Maddipatla | February 1, 2021 | Updated 10:23 IST
Biopharma has remained the dominant industry of the 21st century, and the trend is set to solidify in the post-pandemic world
Over the past year, the world has faced a deadly pandemic and lived through an unexpected economic shutdown. World-over, central banks have been flushing the economy with unprecedented levels of liquidity. And just days before the world marks a year since the first lockdowns came into effect, reports have shown that the global economy is on track to make a faster-than-expected recovery.